What is the current market price of infliximab?

Infliximab (Infliximab) is a humanized monoclonal antibody mainly used to treat a variety of autoimmune diseases, including moderate to severe rheumatoid arthritis, Crohn's disease, ulcerative colitis and moderate to severe psoriasis. As an inhibitor of tumor necrosis factor α (TNF-α), infliximab reduces the inflammatory response by blocking the effect of TNF-α, thereby effectively improving disease symptoms and improving patients' quality of life.

In the Chinese market, infliximab has obtained marketing authorization and is included in medical insurance, which allows many patients to reduce their financial burden through medical insurance reimbursement. Depending on the version and specifications of the medicine, its price ranges from several thousand RMB. Infliximab produced by different manufacturers may have differences in ingredients, dosage and price, but the efficacy is basically the same. Therefore, patients can consult their doctors or pharmacists when purchasing to choose the product that best suits them.

Compared with the domestic situation, the price of original drugs in overseas markets is usually more expensive, and each box may cost up to several thousand dollars. This high price puts many patients who need to use the drug for a long time under financial pressure. Therefore, during the treatment process, patients need to consider the efficacy and cost of the drug. In some cases, patients may choose to purchase drugs from overseas, but they need to pay attention to relevant laws and regulations and import restrictions in individual countries.

It is worth mentioning that the generic version of infliximab is relatively cheap, and its drug ingredients are basically the same as the original drug. The emergence of generic drugs provides another option for many patients with limited financial conditions, helping them to reduce the cost of treatment and obtain the same efficacy as the original drugs as much as possible. However, when using generic drugs, patients still need to follow their doctor's recommendations to ensure the safety and effectiveness of the medication.

Reference materials:https://www.drugs.com/infliximab.html